A detailed history of Jpmorgan Chase & CO transactions in Evolent Health, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,747,107 shares of EVH stock, worth $90.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,747,107
Previous 5,917,684 19.78%
Holding current value
$90.8 Million
Previous $195 Million 20.36%
% of portfolio
0.01%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$29.41 - $34.72 $34.4 Million - $40.6 Million
-1,170,577 Reduced 19.78%
4,747,107 $156 Million
Q4 2023

Feb 12, 2024

SELL
$23.63 - $33.52 $3.09 Million - $4.38 Million
-130,802 Reduced 2.16%
5,917,684 $195 Million
Q3 2023

Nov 14, 2023

BUY
$25.0 - $31.4 $4.47 Million - $5.62 Million
178,993 Added 3.05%
6,048,486 $165 Million
Q2 2023

Aug 11, 2023

BUY
$28.05 - $36.44 $8.67 Million - $11.3 Million
308,943 Added 5.56%
5,869,493 $178 Million
Q1 2023

May 18, 2023

BUY
$26.35 - $35.8 $2.83 Million - $3.84 Million
107,216 Added 1.97%
5,560,550 $180 Million
Q1 2023

May 11, 2023

BUY
$26.35 - $35.8 $2.52 Million - $3.42 Million
95,458 Added 1.78%
5,453,334 $177 Million
Q4 2022

Feb 13, 2023

SELL
$22.21 - $37.41 $10.8 Million - $18.3 Million
-488,129 Reduced 8.35%
5,357,876 $150 Million
Q3 2022

Nov 14, 2022

SELL
$29.37 - $39.74 $7.44 Million - $10.1 Million
-253,244 Reduced 4.15%
5,846,005 $210 Million
Q2 2022

Aug 11, 2022

SELL
$25.9 - $32.26 $1.03 Million - $1.29 Million
-39,843 Reduced 0.65%
6,099,249 $187 Million
Q1 2022

May 11, 2022

BUY
$22.14 - $32.3 $849,378 - $1.24 Million
38,364 Added 0.63%
6,139,092 $198 Million
Q4 2021

Feb 10, 2022

SELL
$25.36 - $34.11 $2.76 Million - $3.71 Million
-108,769 Reduced 1.75%
6,100,728 $169 Million
Q3 2021

Nov 12, 2021

BUY
$20.93 - $31.0 $130 Million - $192 Million
6,209,497 New
6,209,497 $192 Million

Others Institutions Holding EVH

About Evolent Health, Inc.


  • Ticker EVH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 97,063,696
  • Market Cap $1.86B
  • Description
  • Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...
More about EVH
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.